Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Alan J. Levy Sells 2,000 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now owns 25,319 shares in the company, valued at approximately $9,385,753.30. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Intuitive Surgical Stock Up 0.6 %

NASDAQ ISRG opened at $375.33 on Friday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The firm has a market capitalization of $133.13 billion, a P/E ratio of 67.75, a PEG ratio of 4.84 and a beta of 1.36. The company has a 50-day moving average price of $386.19 and a 200-day moving average price of $345.95.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The business’s revenue for the quarter was up 11.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ISRG. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Truist Financial upped their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Barclays upped their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. Finally, StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $396.17.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Norges Bank purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $1,313,238,000. WCM Investment Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $575,536,000. International Assets Investment Management LLC increased its holdings in Intuitive Surgical by 32,360.5% in the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock worth $231,721,000 after acquiring an additional 684,749 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Intuitive Surgical by 111.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock worth $513,056,000 after acquiring an additional 678,375 shares in the last quarter. Finally, Alphinity Investment Management Pty Ltd increased its holdings in Intuitive Surgical by 113.2% in the 4th quarter. Alphinity Investment Management Pty Ltd now owns 1,276,158 shares of the medical equipment provider’s stock worth $430,525,000 after acquiring an additional 677,455 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.